Page 208 - Neuropsychiatric.indd
P. 208
18. Eke S, May SK. Heparin-induced thrombocytopenia treatment and management. [accessed 33. Trajkova S, d'Errico A, Soffietti R, Sacerdote C, Ricceri F. Use of antidepressants and risk of
29 November 2020]. Available from: https://emedicine.medscape.com/article/1357846- incident stroke: a systematic review and meta-analysis. Neuroepidemiology. 2019;53(3-
treatment. 4):142-51.
19. Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and 34. Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circ Res.
management update. Postgrad Med J. 2007;83(983):575-82. 2017;120(3):472-95.
ั
20. Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, et al. American Society 35. สถาบันประสาทวิทยา กรมการแพทย. แนวทางการรกษาโรคหลอดเลอดสมองตบหรออดตนสาหรบ
่
ุ
ั
ื
ั
์
ื
ี
of Hematology 2018 guidelines for management of venous thromboembolism: heparin- แพทย์. กรุงเทพมหานคร: บริษัท ธนาเพลศ จ่ากัด, 2562.
induced thrombocytopenia. Blood Adv. 2018;2(22):3360-92. 36. วิทยาลัยแพทย์ฉุกเฉินแห่งประเทศไทย. แนวทางการรักษาและให้ยาละลายลิ่มเลือดส่าหรับโรคหลอด
21. Epogen (epoetin alfa). Product information. [accessed 29 November 2020]. Available from: เลือดสมองตีบฉับพลันภายนอกโรงพยาบาลและที่ห้องฉุกเฉิน ปี พ.ศ.2563.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103234s5221Lbl.pdf 37. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al.
22. Lexi-drugs online. Lexicomp, Inc.; 2021 [accessed 20 February 2021]. Available from: Guidelines for the early management of patients with acute ischemic stroke: 2019 update
http://online.lexi.com. Subscription required to view. to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for
23. Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, et al. Accuracy of clinical healthcare professionals from the American Heart Association/American Stroke Association.
assessment of deep-vein thrombosis. Lancet. 1995;345(8961):1326-30. Stroke. 2019;50(12):e344-e418.
24. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a 38. Kanjanapan Y, Gilbourd D, Pranavan G. Acute ischaemic stroke following cisplatin-based
simple clinical model to categorize patient probability of pulmonary embolism: increasing chemotherapy for testicular cancer. BMJ Case Rep. 2020;13(5):e235005.
the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83(3):416-20. 39. Ramasubbu R. SSRI treatment-associated stroke: causality assessment in two cases. Ann
25. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Pharmacother. 2004;38(7-8):1197-201.
Hematology 2020 guidelines for management of venous thromboembolism: treatment of 40. American Stroke Association. Hemorrhagic stroke. [accessed 29 November 2020]. Available
deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-738. from: https://www.stroke.org/en/about-stroke/types-of-stroke/hemorrhagic-strokes-bleeds
26. Cui X, Wan Z, Ma Z, Liu L, Yang Y. Occurrence of acute pulmonary embolism induced by 41. Burrage DR. Drug causes of intracerebral hemorrhage. Adverse drug reaction bulletin.
recombinant erythropoietin during treatment of pure red cell aplasia associated with 2019;318:1231-4.
thymoma: A case report. Medicine (Baltimore). 2019;98(10):e14789. 42. Hu Y, Ji C. Efficacy and safety of thrombolysis for acute ischemic stroke with atrial
27. Flannery MT, Humphrey D. Deep venous thrombosis with pulmonary embolism related to fibrillation: a meta-analysis. BMC Neurol. 2021;21(1):66.
IVIg treatment: A case report and literature review. Case Rep Med. 2015:971321. 43. Dogliotti A, Paolasso E, Giugliano RP. Novel oral anticoagulants in atrial fibrillation: a meta-
28. Rhoney DH. Chapter 11 Stroke. In: Tisdale JE et al., eds. Drug-Induced Diseases: analysis of large, randomized, controlled trials vs warfarin. Clin Cardiol. 2013;36(2):61-7.
Prevention, Detection, and Management. 3rd ed. United States: American Society of 44. Islam MM, Poly TN, Walther BA, Yang HC, Lin MC, Li YC. Risk of hemorrhagic stroke in
Health-System Pharmacists, Inc., 2018. patients exposed to nonsteroidal anti-inflammatory drugs: a meta-analysis of
29. Ryan M, Nestor M. Chapter 38 Stroke. In: Dipiro JT et al., eds. Pharmacotherapy: A observational studies. Neuroepidemiology. 2018;51(3-4):166-76.
pathophysiologic approach. 11th ed. United States: McGraw Hill Companies, Inc, 2020. 45. An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral
์
ั
่
30. สถาบนประสาทวิทยา กรมการแพทย. คมอโรคหลอดเลอดสมอง (อมพาต อมพฤกษ) สาหรบประชาชน. hemorrhage: An Update. J Stroke. 2017;19(1):3-10.
ั
ั
่
์
ั
ื
ื
ู
2556 46. Tatro DS. eds. Drug Interaction Facts. United States: Wolter Kluwer Health, Inc., 2015.
ู
้
่
31. Siddiqui F, Qureshi A. Medication-induced stroke. In Tsiskaridze A et al., eds. Treatment- 47. สถาบนประสาทวิทยา กรมการแพทย์. คมอในการดแลรักษาผปวยโรคหลอดเลอดสมองแตก.
ื
ู
ู
่
ั
ื
Related Stroke: Including Iatrogenic and In-Hospital Strokes. Cambridge: Cambridge กรุงเทพมหานคร: บริษัท ธนาเพลศ จ่ากัด, 2562.
University Press, 2016. 48. Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke
32. Burrage DR. Drug causes of ischemic stroke. Adverse drug reaction bulletin. 2019;316:1223- Vasc Neurol. 2017;2(1):21-29.
6. 49. Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al.
Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for
186 187
187

